1 min read.Updated: 21 Jul 2022, 01:56 PM ISTLivemint
Gland Pharma shares are down more than 40% in 2022 (YTD) so far
Listen to this article
Shares of Gland Pharma plunged to ₹2,180 apiece on the BSE, hitting a 52-week low level in Thursday's trading session after reporting weak set of earnings for the first quarter ending June 2022 with consolidated revenue declining by 25.7% year-on-year due to weak performance in geographies such as US, India.
Recommended For You
Select your Category
Internet Not Available
Wait for it…
Log in to our website to save your bookmarks. It'll just take a moment.